Vaccines
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
2,631
NCT03025750
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age
Phase: Phase 3
Role: Collaborator
Start: Jan 19, 2017
Completion: Nov 14, 2017
NCT03032419
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months
Start: Feb 6, 2017
Completion: Mar 12, 2018
NCT03671616
Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months
Start: May 15, 2018
Completion: Oct 3, 2018
NCT04448132
Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)
Phase: Phase 4
Role: Lead Sponsor
Start: Nov 20, 2020
Completion: May 3, 2021
Loading map...